QM · rank #3 · 2026-10-27
JEN
XETRA · EUR · $2.40B (USD)
The exact numbers the algorithm saw.
| Momentum 12-1 Return from 12 months ago to 1 month ago. | +137.87% |
|---|---|
| ROE TTM Return on equity, trailing 12 months. | +8.8% |
| Profit margin Net profit margin, trailing 12 months. | +8.3% |
| Market cap (USD) Size filter: > $300M required (USD-equivalent). | $2.40B |
| Anchor (recent) Close on 2026-09-25 | $40.68 |
| Anchor (far) Close on 2025-09-26 | $17.10 |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Jenoptik is a German photonics and precision-optics company supplying semiconductor equipment, medical, metrology and smart-mobility customers with high-end optical components and systems, holding sole-supplier status on select products.
Rationale
Strong 12-1 momentum (1.38) is directly reinforced by a concrete fundamental catalyst — a guidance upgrade to ~22% EBITDA margin, 53% H1 order-intake growth, and accelerating semiconductor-equipment demand — making this a momentum signal with visible earnings-revision support rather than pure sentiment.
Material risks
- 1Customer concentration (top 7 = ~43% of 2025 revenue) combined with sole-supplier exposure means a single insourcing decision or vendor switch by a major semiconductor-equipment OEM could abruptly collapse both revenue and the quality thesis.
- 2Semiconductor-equipment demand is inherently cyclical, and the current order surge (€1.1 bn intake vs. €777 mn prior year) may front-load backlog conversion, leaving 2027 revenue growth vulnerable to a capex digestion pause at key OEM customers.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.